Novo Nordisk

News

Graphic of faceless person with board in front of them reading Coming Soon on orange background

UK watchdog takes first action on oral weight drug adverts

Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.

News

Novo faces delay in US review of haemophilia drug

The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.

News

New diabetes and obesity studies making waves at EASD

As the EASD congress draws to a close, here's a round-up of some of the other clinical trials in diabetes and obesity that drew our attention.

News

Two men charged with infiltrating fake Ozempic into US

Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.

News

Novo turns to Hengrui for another oral obesity drug

Novo has agreed to pay up to $2.6 billion for rights to a weight-loss pill, developed by China's Hengrui Pharma, that could be dosed just once a week.

News

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik, setting up a market tussle with Novo's recently launched Awiqli.

UK watchdog takes first action on oral weight drug adverts

Novo faces delay in US review of haemophilia drug

New diabetes and obesity studies making waves at EASD

Two men charged with infiltrating fake Ozempic into US

Novo turns to Hengrui for another oral obesity drug

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Novo Nordisk

Editor's Picks